Vetoquinol Financials
| VETO Stock | EUR 79.00 0.30 0.38% |
Vetoquinol |
Understanding current and past Vetoquinol Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Vetoquinol's financial statements are interrelated, with each one affecting the others. For example, an increase in Vetoquinol's assets may result in an increase in income on the income statement.
Please note, the presentation of Vetoquinol's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Vetoquinol's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Vetoquinol's management manipulating its earnings.
Vetoquinol Stock Summary
Vetoquinol competes with Virbac SA, Thermador Groupe, Robertet, Trigano SA, and Neurones. Vetoquinol SA, a veterinary pharmaceutical company, designs, develops, and sells veterinary drugs and non-medicinal products in Europe, the Americas, and the Asia Pacific region. Vetoquinol SA was founded in 1933 and is headquartered in Lure, France. Vetoquinol operates under Drug Manufacturers - Major classification in France and is traded on Paris Stock Exchange. It employs 2004 people.| Foreign Associate | India |
| Instrument | France Stock View All |
| Exchange | Euronext Paris |
| ISIN | FR0004186856 |
| Business Address | Magny-Vernois, Lure, France, |
| Sector | Pharmaceuticals |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.vetoquinol.com |
| Phone | 33 3 84 62 55 55 |
| Currency | EUR - Euro |
You should never invest in Vetoquinol without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Vetoquinol Stock, because this is throwing your money away. Analyzing the key information contained in Vetoquinol's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Vetoquinol Key Financial Ratios
Vetoquinol's financial ratios allow both analysts and investors to convert raw data from Vetoquinol's financial statements into concise, actionable information that can be used to evaluate the performance of Vetoquinol over time and compare it to other companies across industries.| Return On Equity | 0.11 | |||
| Return On Asset | 0.0774 | |||
| Target Price | 109.4 | |||
| Beta | 0.79 | |||
| Z Score | 80.4 |
Vetoquinol Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Vetoquinol's current stock value. Our valuation model uses many indicators to compare Vetoquinol value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Vetoquinol competition to find correlations between indicators driving Vetoquinol's intrinsic value. More Info.Vetoquinol is rated first in return on equity category among its peers. It is rated first in return on asset category among its peers reporting about 0.70 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Vetoquinol is roughly 1.42 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Vetoquinol by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Vetoquinol's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Vetoquinol Systematic Risk
Vetoquinol's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Vetoquinol volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twelve with a total number of output elements of fourty-nine. The Beta measures systematic risk based on how returns on Vetoquinol correlated with the market. If Beta is less than 0 Vetoquinol generally moves in the opposite direction as compared to the market. If Vetoquinol Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Vetoquinol is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Vetoquinol is generally in the same direction as the market. If Beta > 1 Vetoquinol moves generally in the same direction as, but more than the movement of the benchmark.
Vetoquinol November 26, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Vetoquinol help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Vetoquinol. We use our internally-developed statistical techniques to arrive at the intrinsic value of Vetoquinol based on widely used predictive technical indicators. In general, we focus on analyzing Vetoquinol Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Vetoquinol's daily price indicators and compare them against related drivers.
| Information Ratio | (0.21) | |||
| Maximum Drawdown | 10.23 | |||
| Value At Risk | (3.02) | |||
| Potential Upside | 2.95 |
Complementary Tools for Vetoquinol Stock analysis
When running Vetoquinol's price analysis, check to measure Vetoquinol's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vetoquinol is operating at the current time. Most of Vetoquinol's value examination focuses on studying past and present price action to predict the probability of Vetoquinol's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vetoquinol's price. Additionally, you may evaluate how the addition of Vetoquinol to your portfolios can decrease your overall portfolio volatility.
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |